These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39366392)

  • 1. Early integration of palliative care versus standard cardiac care for patients with heart failure (EPCHF): a multicentre, parallel, two-arm, open-label, randomised controlled trial.
    Balata M; Radbruch L; Hesse M; Westenfeld R; Neukirchen M; Pfister R; Batzler YN; Öztürk C; Kavsur R; Tiyerili V; Weltermann B; Pölsler R; Standl T; Nickenig G; Becher MU;
    Lancet Healthy Longev; 2024 Oct; 5(10):100637. PubMed ID: 39366392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an Early Palliative Care Telehealth Intervention vs Usual Care on Patients With Heart Failure: The ENABLE CHF-PC Randomized Clinical Trial.
    Bakitas MA; Dionne-Odom JN; Ejem DB; Wells R; Azuero A; Stockdill ML; Keebler K; Sockwell E; Tims S; Engler S; Steinhauser K; Kvale E; Durant RW; Tucker RO; Burgio KL; Tallaj J; Swetz KM; Pamboukian SV
    JAMA Intern Med; 2020 Sep; 180(9):1203-1213. PubMed ID: 32730613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.
    Rogers JG; Patel CB; Mentz RJ; Granger BB; Steinhauser KE; Fiuzat M; Adams PA; Speck A; Johnson KS; Krishnamoorthy A; Yang H; Anstrom KJ; Dodson GC; Taylor DH; Kirchner JL; Mark DB; O'Connor CM; Tulsky JA
    J Am Coll Cardiol; 2017 Jul; 70(3):331-341. PubMed ID: 28705314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF).
    Becher MU; Balata M; Hesse M; Draht F; Zachoval C; Weltermann B; Westenfeld R; Neukirchen M; Pfister R; Standl T; Radbruch L; Nickenig G
    Clin Res Cardiol; 2022 Apr; 111(4):359-367. PubMed ID: 34241674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial.
    Bradley TD; Logan AG; Lorenzi Filho G; Kimoff RJ; Durán Cantolla J; Arzt M; Redolfi S; Parati G; Kasai T; Dunlap ME; Delgado D; Yatsu S; Bertolami A; Pedrosa R; Tomlinson G; Marin Trigo JM; Tantucci C; Floras JS;
    Lancet Respir Med; 2024 Feb; 12(2):153-166. PubMed ID: 38142697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.
    Brugts JJ; Radhoe SP; Clephas PRD; Aydin D; van Gent MWF; Szymanski MK; Rienstra M; van den Heuvel MH; da Fonseca CA; Linssen GCM; Borleffs CJW; Boersma E; Asselbergs FW; Mosterd A; Brunner-La Rocca HP; de Boer RA;
    Lancet; 2023 Jun; 401(10394):2113-2123. PubMed ID: 37220768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.
    Koehler F; Koehler K; Deckwart O; Prescher S; Wegscheider K; Kirwan BA; Winkler S; Vettorazzi E; Bruch L; Oeff M; Zugck C; Doerr G; Naegele H; Störk S; Butter C; Sechtem U; Angermann C; Gola G; Prondzinsky R; Edelmann F; Spethmann S; Schellong SM; Schulze PC; Bauersachs J; Wellge B; Schoebel C; Tajsic M; Dreger H; Anker SD; Stangl K
    Lancet; 2018 Sep; 392(10152):1047-1057. PubMed ID: 30153985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
    Mebazaa A; Davison B; Chioncel O; Cohen-Solal A; Diaz R; Filippatos G; Metra M; Ponikowski P; Sliwa K; Voors AA; Edwards C; Novosadova M; Takagi K; Damasceno A; Saidu H; Gayat E; Pang PS; Celutkiene J; Cotter G
    Lancet; 2022 Dec; 400(10367):1938-1952. PubMed ID: 36356631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure.
    Clark AL; Johnson M; Fairhurst C; Torgerson D; Cockayne S; Rodgers S; Griffin S; Allgar V; Jones L; Nabb S; Harvey I; Squire I; Murphy J; Greenstone M
    Health Technol Assess; 2015 Sep; 19(75):1-120. PubMed ID: 26393373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
    Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
    Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation.
    Mackenzie IS; Hawkey CJ; Ford I; Greenlaw N; Pigazzani F; Rogers A; Struthers AD; Begg AG; Wei L; Avery AJ; Taggar JS; Walker A; Duce SL; Barr RJ; Dumbleton JS; Rooke ED; Townend JN; Ritchie LD; MacDonald TM;
    Health Technol Assess; 2024 Mar; 28(18):1-55. PubMed ID: 38551218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial.
    Vanbutsele G; Pardon K; Van Belle S; Surmont V; De Laat M; Colman R; Eecloo K; Cocquyt V; Geboes K; Deliens L
    Lancet Oncol; 2018 Mar; 19(3):394-404. PubMed ID: 29402701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic: The PRO-HF Trial.
    Sandhu AT; Calma J; Skye M; Kalwani N; Zheng J; Schirmer J; Din N; Brown Johnson C; Gupta A; Lan R; Yu B; Spertus JA; Heidenreich PA
    Circulation; 2024 May; 149(22):1717-1728. PubMed ID: 38583147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.
    Abraham WT; Stevenson LW; Bourge RC; Lindenfeld JA; Bauman JG; Adamson PB;
    Lancet; 2016 Jan; 387(10017):453-61. PubMed ID: 26560249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol.
    Golla H; Nettekoven C; Bausewein C; Tonn JC; Thon N; Feddersen B; Schnell O; Böhlke C; Becker G; Rolke R; Clusmann H; Herrlinger U; Radbruch L; Vatter H; Güresir E; Stock S; Müller D; Civello D; Papachristou I; Hellmich M; Hamacher S; Voltz R; Goldbrunner R;
    BMJ Open; 2020 Jan; 10(1):e034378. PubMed ID: 31915175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
    Spertus JA; Fine JT; Elliott P; Ho CY; Olivotto I; Saberi S; Li W; Dolan C; Reaney M; Sehnert AJ; Jacoby D
    Lancet; 2021 Jun; 397(10293):2467-2475. PubMed ID: 34004177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.
    Cools F; Virdone S; Sawhney J; Lopes RD; Jacobson B; Arcelus JI; Hobbs FDR; Gibbs H; Himmelreich JCL; MacCallum P; Schellong S; Haas S; Turpie AGG; Ageno W; Rocha AT; Kayani G; Pieper K; Kakkar AK;
    Lancet Haematol; 2022 Aug; 9(8):e594-e604. PubMed ID: 35779560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial.
    Loeb M; Roy A; Dokainish H; Dans A; Palileo-Villanueva LM; Karaye K; Zhu J; Liang Y; Goma F; Damasceno A; Alhabib KF; Yonga G; Mondo C; Almahmeed W; Al Mulla A; Thanabalan V; Rao-Melacini P; Grinvalds A; McCready T; Bangdiwala SI; Yusuf S;
    Lancet Glob Health; 2022 Dec; 10(12):e1835-e1844. PubMed ID: 36400089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.